Summary of Classification and Labelling
Notified classification and labelling
General Information
922-049-5 |
3-[1-(4-{Methyl-[2-(4-methyl-piperazin-1-yl)-acetyl]-amino}-phenylamino)-1-phenyl-meth-(Z)-ylidene]-2-oxo-2,3-dihydro-1H-indole-6-ca |
|
Notified classification and labelling according to CLP criteria
Repr. 1B |
H360
(oral)
(teratogenic eff...)
|
H360
|
|
GHS08 Dgr
|
|
|
|
|
2 |
|
View details
|
STOT RE 2 |
H373
(most serious: b...)
(oral)
|
H373
|
Number of Aggregated Notifications: 1